Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5-(1,3-bis(hydroxymethyl)ureido)-1,3-bis(hydroxymethyl)imidazol-2,5(3h,5h)dione
2. Diazolidinylurea
3. Germall Ii
1. 78491-02-8
2. Diazolidinylurea
3. 1-(1,3-bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)-1,3-bis(hydroxymethyl)urea
4. Germall Ii
5. N,n'-bis(hydroxymethyl) Urea
6. 1-[1,3-bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxymethyl)urea
7. N-(1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)-n,n'-bis(hydroxymethyl)urea
8. N9vx1ibw6k
9. N-[1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]-n,n'-bis(hydroxymethyl)urea
10. Mfcd03547942
11. Dsstox_cid_9559
12. Dsstox_rid_78776
13. Urea, N-(1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)-n,n'-bis(hydroxymethyl)-
14. Urea, N-[1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]-n,n'-bis(hydroxymethyl)-
15. Dsstox_gsid_29559
16. Germall 11
17. Imidazolidinyl Urea 11
18. Cas-78491-02-8
19. Einecs 278-928-2
20. Unii-h5riz3mpw4
21. Unii-n9vx1ibw6k
22. H5riz3mpw4
23. Ec 278-928-2
24. Diazolidinyl Urea, >=95%
25. N-(hydroxymethyl)-n-(1,3-dihydroxymethyl-2,5-dioxo-4-imidazolidinyl)-n'-(hydroxymethyl) Urea
26. N-(hydroxymethyl)-n-(1,3-dihydroxymethyl-2,5-dioxo-4-imidazolidinyl)-n'-(hydroxymethyl)urea
27. Schembl34370
28. Chembl3187032
29. Dtxsid0029559
30. N-(1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)-
31. Chebi:136014
32. Tox21_202068
33. Tox21_303365
34. Ac1192
35. S5292
36. Akos016010254
37. Ccg-267223
38. Cs-w010066
39. Db14173
40. Hy-w009350
41. Urea, N-(1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl-n,n'-bis(hyd- Roxymethyl)-
42. Ncgc00249159-01
43. Ncgc00257237-01
44. Ncgc00259617-01
45. As-73729
46. N-[1,3-bis(hydroxymethyl)-2,5-dioxo(1,3-diazolidin-4-yl)]-n-(hydroxymethyl)[(h Ydroxymethyl)amino]carboxamide
47. Sy033470
48. Db-056316
49. D3769
50. Ft-0641680
51. Q5272201
52. W-104279
53. 1,3-bis(hydroxymethyl)-5-[1,3-bis(hydroxymethyl)ureido]hydantoin
54. N,n'-bis(hydroxymethyl)-n'-(1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)urea
55. N-hydroxymethyl-n-(1,3-di(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)-n'-hydroxy-methylurea
56. N-[1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]-n,n Inverted Exclamation Mark -bis(hydroxymethyl)urea
Molecular Weight | 278.22 g/mol |
---|---|
Molecular Formula | C8H14N4O7 |
XLogP3 | -2.5 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 278.08624880 g/mol |
Monoisotopic Mass | 278.08624880 g/mol |
Topological Polar Surface Area | 154 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 376 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
95
PharmaCompass offers a list of Diazolidinylurea API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diazolidinylurea manufacturer or Diazolidinylurea supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diazolidinylurea manufacturer or Diazolidinylurea supplier.
PharmaCompass also assists you with knowing the Diazolidinylurea API Price utilized in the formulation of products. Diazolidinylurea API Price is not always fixed or binding as the Diazolidinylurea Price is obtained through a variety of data sources. The Diazolidinylurea Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Diazolidinylurea manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diazolidinylurea, including repackagers and relabelers. The FDA regulates Diazolidinylurea manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diazolidinylurea API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Diazolidinylurea supplier is an individual or a company that provides Diazolidinylurea active pharmaceutical ingredient (API) or Diazolidinylurea finished formulations upon request. The Diazolidinylurea suppliers may include Diazolidinylurea API manufacturers, exporters, distributors and traders.
Diazolidinylurea Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diazolidinylurea GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diazolidinylurea GMP manufacturer or Diazolidinylurea GMP API supplier for your needs.
A Diazolidinylurea CoA (Certificate of Analysis) is a formal document that attests to Diazolidinylurea's compliance with Diazolidinylurea specifications and serves as a tool for batch-level quality control.
Diazolidinylurea CoA mostly includes findings from lab analyses of a specific batch. For each Diazolidinylurea CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diazolidinylurea may be tested according to a variety of international standards, such as European Pharmacopoeia (Diazolidinylurea EP), Diazolidinylurea JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diazolidinylurea USP).